Becton Dickinson Stock - Analyst consensus steadies at Hold
17.06.2026 - 20:14:38 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 20:09 CET. Details in the imprint.
Becton Dickinson (US0718131099) holds a consensus Hold rating from covering analysts, according to a MarketBeat survey dated 06/17/2026, while chart signals look somewhat soft on TradingView. The medtech group keeps focusing on operational execution and stable demand across its diagnostics and medical-surgical businesses.
All news and analysis on Becton Dickinson stock
Track fresh analyst views, operating updates and price data for Becton Dickinson stock in one place on ad-hoc-news.de.
What MarketBeat reports on ratings
According to a MarketBeat analyst roundup dated 06/17/2026, Becton, Dickinson and Company carries a consensus recommendation of Hold from 16 brokerages covering the stock.
The same compilation cites a twelve-month share price range between a low of $127.59 and a high of $187.35, underlining the volatility that medtech investors have had to digest over the past year.
Wednesday focus on operations and strategy
The Hold stance fits a broader narrative of Becton Dickinson as a steady compounder in medical devices and consumables, with investors tracking execution rather than dramatic strategic shifts.
The group continues to emphasize recurring revenue from syringes, catheters, IV sets and diagnostic instruments, a positioning that has historically cushioned earnings against sharp swings in hospital capital spending cycles.
The product behind the stock
Becton Dickinson generates a significant share of its revenue from disposable medical products such as syringes, needles and infusion sets used in hospitals, clinics and labs worldwide, alongside diagnostic platforms and medication delivery systems.
Where the stock trades today
Becton Dickinson shares (US0718131099) last traded on the New York Stock Exchange at $146.41 on 06/17/2026, based on recent quote data, with the price reflecting a subdued near-term technical picture.
Key facts on Becton Dickinson stock
- Company: Becton, Dickinson and Company
- ISIN: US0718131099
- WKN: 857675
- Ticker: BDX
- Venue: NYSE
- Price (as of 06/17/2026, 20:09 CET): 146.41 USD
- Market cap: 42,000,000,000 USD (as of 06/17/2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
